176 related articles for article (PubMed ID: 14693046)
1. [Effects of two LMP1 variants on resistance of CNE1 cell strain to TGF-beta1].
Huang H; Huang PC
Ai Zheng; 2003 Dec; 22(12):1254-9. PubMed ID: 14693046
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1].
Chen Y; Chen XY
Ai Zheng; 2002 May; 21(5):498-503. PubMed ID: 12452040
[TBL] [Abstract][Full Text] [Related]
3. [Effect of EB virus latent membrane protein 1 on mitosis control of nasopharyngeal carcinoma cell line CNE1].
Liu B; Chen XY
Ai Zheng; 2004 May; 23(5):512-6. PubMed ID: 15142445
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Epstein-Barr virus latent membrane protein 1(EBV-LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1].
Gou XM; Chen Y; Chen XY; Arrand JR
Ai Zheng; 2003 May; 22(5):481-5. PubMed ID: 12753707
[TBL] [Abstract][Full Text] [Related]
5. [Effects of Epstein-Barr virus latent membrane protein 1 on metastasis of human nasopharyngeal carcinoma cell lines].
Ou XB; Chen XY; Wu MH; Luo WR
Ai Zheng; 2008 Aug; 27(8):803-8. PubMed ID: 18710612
[TBL] [Abstract][Full Text] [Related]
6. [Impact of up-regulating Ezrin expression by Epstein-Barr virus latent membrane protein 1 on metastasis ability of nasopharyngeal carcinoma cells].
Shen ZH; Chen XY; Chen J
Ai Zheng; 2008 Feb; 27(2):165-9. PubMed ID: 18279614
[TBL] [Abstract][Full Text] [Related]
7. Effect of inhibition of EBV-encoded latent membrane protein-1 by small interfering RNA on EBV-positive nasopharyngeal carcinoma cell growth.
Li G; Li XP; Peng Y; Liu X; Li XH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):241-6. PubMed ID: 15041532
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.
Stevenson D; Charalambous C; Wilson JB
Cancer Res; 2005 Oct; 65(19):8826-35. PubMed ID: 16204053
[TBL] [Abstract][Full Text] [Related]
10. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
Nitta T; Chiba A; Yamamoto N; Yamaoka S
Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
[TBL] [Abstract][Full Text] [Related]
11. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity.
Blake SM; Eliopoulos AG; Dawson CW; Young LS
Virology; 2001 Apr; 282(2):278-87. PubMed ID: 11289810
[TBL] [Abstract][Full Text] [Related]
12. Biological properties of TW01 cells expressing latent membrane protein-1 gene of EBV-derived from nasopharyngeal carcinoma cells at different stages of malignancy.
Tan EL; Sam CK
Exp Oncol; 2007 Sep; 29(3):166-74. PubMed ID: 18004239
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
14. Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma.
Hu L; Troyanovsky B; Zhang X; Trivedi P; Ernberg I; Klein G
Cancer Res; 2000 Oct; 60(19):5589-93. PubMed ID: 11034108
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of leukocyte infiltration in murine tumors expressing B-cell derived but not nasopharyngeal carcinoma derived EBV membrane protein LMP1.
Trivedi P; Cuomo L; Christensson B; Hu LF; Morrone S; Frati L; Faggioni A; Winberg G; Klein G
J Med Virol; 2000 Apr; 60(4):417-24. PubMed ID: 10686025
[TBL] [Abstract][Full Text] [Related]
16. [Epstein-Barr virus-encoded latent membrane protein 1 mediates serine-phosphorylation of annexin I by activating protein kinase C].
Yan GR; Luo W; Luo XJ; Cao Y
Ai Zheng; 2007 Jul; 26(7):679-82. PubMed ID: 17626739
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
18. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
19. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells.
Dawson CW; Eliopoulos AG; Blake SM; Barker R; Young LS
Virology; 2000 Jun; 272(1):204-17. PubMed ID: 10873763
[TBL] [Abstract][Full Text] [Related]
20. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
